Skip to main content

Table 1 Baseline data (\( \overline{x} \)±s)

From: Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Group

Patients

Age (years)

DBP (mmHg)

SBP (mmHg)

BMI (kg/m2)

 Diabetes

200

52 ± 0.25

75 ± 13

120 ± 14.5

24.8 ± 0.5

 Diabetes combined with hyperlipidemia

195

58 ± 0.18a

98 ± 9a

149 ± 13.5a

26.9 ± 0.8a

Group

Total cholesterol (mmol/L)

HDL (mmol/L)

LDL (mmol/L)

Smoking (%)

 Diabetes

5.2 ± 0.89

1.75 ± 0.18

1.36 ± 0.12

23.8%

 Diabetes combined with hyperlipidemia

5.9 ± 0.67a

2.68 ± 0.38a

2.45 ± 0.36a

38.5%a

Group

FPG (mmol/L)

Hypertension (%)

Obesity (%)

Follow-up period (year)

hs-CRP (mg/L)

 Diabetes

9.45 ± 0.16

21.8

19.8

4.0 (3.8–4.2)

1.86 ± 0.45

 Diabetes combined with hyperlipidemia

9.04 ± 0.38a

35.9a

29.7a

4.2 (3.7–4.4)a

9.65 ± 0.82a

  1. Note: DBP diastolic blood pressure, SBP systolic blood pressure, BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, FPG fasting plasma glucose, hs-CRP hyper-sensitive C-reactive protein
  2. aP < 0.05